Literature DB >> 24900508

Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues.

Huayun Deng1, Ye Fang1.   

Abstract

5,6-Dihydroxyindole-2-carboxylic acid (DHICA), an intermediate of melanin synthesis and an eumelanin building block, was recently discovered to be a GPR35 agonist with moderate potency. Here, we report the synthesis and pharmacological characterization of a series of DHICA analogues against GPR35 using both label-free dynamic mass redistribution and Tango β-arrestin translocation assays. This led to identification of novel GPR35 agonists with improved potency and/or having biased agonism.

Entities:  

Keywords:  5,6-dihydroxyindole-2-carboxylic acid; GPR35; biased agonism; melanin synthesis

Year:  2012        PMID: 24900508      PMCID: PMC4030800          DOI: 10.1021/ml300076u

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  15 in total

1.  GPR35 is a target of the loop diuretic drugs bumetanide and furosemide.

Authors:  Yuhua Yang; Angela Fu; Xiaosu Wu; Jeff D Reagan
Journal:  Pharmacology       Date:  2012-01-10       Impact factor: 2.547

2.  Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.

Authors:  Jinghong Wang; Nicole Simonavicius; Xiaosu Wu; Gayathri Swaminath; Jeff Reagan; Hui Tian; Lei Ling
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

3.  Resonant waveguide grating biosensor for living cell sensing.

Authors:  Ye Fang; Ann M Ferrie; Norman H Fontaine; John Mauro; Jitendra Balakrishnan
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

4.  GPR35 is a novel lysophosphatidic acid receptor.

Authors:  Saori Oka; Ryo Ota; Mitsuru Shima; Atsushi Yamashita; Takayuki Sugiura
Journal:  Biochem Biophys Res Commun       Date:  2010-03-31       Impact factor: 3.575

5.  Tyrphostin analogs are GPR35 agonists.

Authors:  Huayun Deng; Haibei Hu; Ye Fang
Journal:  FEBS Lett       Date:  2011-05-17       Impact factor: 4.124

6.  G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium.

Authors:  Yuhua Yang; Jenny Ying-Lin Lu; Xiaosu Wu; Shamin Summer; John Whoriskey; Christiaan Saris; Jeff D Reagan
Journal:  Pharmacology       Date:  2010-06-19       Impact factor: 2.547

7.  Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.

Authors:  Pingwei Zhao; Haleli Sharir; Ankur Kapur; Alan Cowan; Ellen B Geller; Martin W Adler; Herbert H Seltzman; Patricia H Reggio; Susanne Heynen-Genel; Michelle Sauer; Thomas D Y Chung; Yushi Bai; Wei Chen; Marc G Caron; Larry S Barak; Mary E Abood
Journal:  Mol Pharmacol       Date:  2010-07-22       Impact factor: 4.436

8.  GPR35 as a Novel Therapeutic Target.

Authors:  A E Mackenzie; J E Lappin; D L Taylor; S A Nicklin; G Milligan
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-09       Impact factor: 5.555

9.  Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists.

Authors:  Huayun Deng; Haibei Hu; Mingqian He; Jieyu Hu; Weijun Niu; Ann M Ferrie; Ye Fang
Journal:  J Med Chem       Date:  2011-10-04       Impact factor: 7.446

10.  Multiple tyrosine metabolites are GPR35 agonists.

Authors:  Huayun Deng; Haibei Hu; Ye Fang
Journal:  Sci Rep       Date:  2012-04-20       Impact factor: 4.379

View more
  7 in total

1.  SAR Studies of N-[2-(1H-Tetrazol-5-yl)phenyl]benzamide Derivatives as Potent G Protein-Coupled Receptor-35 Agonists.

Authors:  Lai Wei; Tao Hou; Chang Lu; Jixia Wang; Xiuli Zhang; Ye Fang; Yaopeng Zhao; Jiatao Feng; Jiaqi Li; Lala Qu; Hai-Long Piao; Xinmiao Liang
Journal:  ACS Med Chem Lett       Date:  2018-04-09       Impact factor: 4.345

2.  Syntheses of PDE3A inhibitor ORG9935 and determination of the absolute stereochemistries of its enantiomers by X-ray crystallography.

Authors:  Sudhakar Jakkaraj; Victor G Young; Gunda I Georg
Journal:  Tetrahedron       Date:  2018-04-18       Impact factor: 2.457

3.  Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.

Authors:  Jeffery J Newsome; Mary Hassani; Elizabeth Swann; Jane M Bibby; Howard D Beall; Christopher J Moody
Journal:  Bioorg Med Chem       Date:  2013-04-06       Impact factor: 3.641

4.  Biological activity and synthesis of 5,6-dihydroxyindole-2-carboxylic acid - biosynthetic precursor of melanins (microreview).

Authors:  Mikhail А Barabanov; Georgii S Martyanov; Alexander V Pestov
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-14       Impact factor: 1.277

5.  Expedient synthesis of eumelanin-inspired 5,6-dihydroxyindole-2-carboxylate ethyl ester derivatives.

Authors:  Andrew H Aebly; Jeffrey N Levy; Benjamin J Steger; Jonathan C Quirke; Jason M Belitsky
Journal:  RSC Adv       Date:  2018-08-07       Impact factor: 3.361

Review 6.  Label-free drug discovery.

Authors:  Ye Fang
Journal:  Front Pharmacol       Date:  2014-03-27       Impact factor: 5.810

7.  The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists.

Authors:  Huayun Deng; Ye Fang
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.